GACP. GMP. GDP. Three standards. One mindset.
Reproducibility is no coincidence. It is the result of documented processes, external audits and a Responsible Person who knows every batch — before it reaches a Swiss pharmacy.
From seedling to pharmacy: GxP without gaps.
We work exclusively with partners who meet all relevant good-practice standards. Every level is certified, every hand-over documented. Select a level to see the details.
Good Agricultural & Collection Practice
Standardised cultivation in a controlled environment — greenhouse or indoor. The goal is a reproducible result: defined process parameters, trained staff and continuous traceability through to hand-over to GMP manufacturing. Guidance is provided by the EU GACP guideline (EMA/HMPC) together with the WHO GACP requirements.
The final check happens with us.
Even if a batch was already manufactured under EU-GMP conditions, it does not enter the Swiss market unchecked. Every partner first undergoes a complete due diligence — select a step to see it in detail.
Document review & licence check
On-site audit
Quality agreement
Admission to the network
RP release in Switzerland
Every batch. Fully documented.
GACP in cultivation, GMP in manufacturing, GDP in logistics — these letter sequences stand for reproducibility. Four things are part of every delivery for us.
Certificate of Analysis
Complete cannabinoid and terpene analysis. Microbiology per Ph.Eur. 5.1.8-B, pesticides per Ph.Eur. 2.8.13, heavy metals and mycotoxins — for every batch individually.
Temperature control
Unbroken cold chain from the GDP warehouse to the doorstep of your pharmacy. Temperature monitoring of every shipment, active cooling on critical routes.
Traceability
Every batch is documented from the cultivation partner's seedling to the point of sale. On request we are happy to answer questions about our supply chain.
Manufacturer-independent
We deliberately do not run our own cultivation. This independence allows us to judge every cultivation partner purely on quality.
A patient in Lausanne should receive the same quality in July as a patient in St. Gallen in December. Reproducibility is not a promise — it is verifiable, batch after batch.